Testing is one piece of reopening, but experts are still relying on the help of a vaccine to keep the public safe. Researchers are increasingly optimistic that scientists are getting closer to development even though we’re barely months into identifying and learning about the novel strain of SARS. Human and clinical trials are well underway, but just when they’ll be ready for manufacturing and distribution is another story. What is a realistic timeline and does one exist? We asked Dr. Vincent Silenzio an expert in urban and global public health at Rutgers University. To read the full story.
Recent Posts
- Estrogen Patch Shortages Are Ongoing—Here’s Where to Find Them and What to Ask Your Doctor.
- Toddlers are getting their hands on e-cigarettes and inhaling at an alarming rate, new Rutgers study shows.
- Rutgers deans: We train advanced practice nurses for N.J. Our laws send them elsewhere.
- Push for raw milk intensifies across the US, despite illness outbreaks and scientists’ warnings.
- Princeton undergraduates build real-world skills through community health micro-internships.
Categories
- Community (2,494)
- Covid (1,001)
- CTO Events (6)
- News (3,166)
- Pilots (21)